Latham Wins Dismissal of Securities Action Involving Liver Disease Drug Developer
The case involved a clinical trial of Akero’s only product, a drug candidate aimed at treating a liver disease. It’s the second time U.S. District Judge Yvonne Gonzalez Rogers has ordered dismissal.
CEO of Speaker Media and Marketing, is the "Secret Weapon of Personal Injury Lawyers and Trial Attorneys" throughout the United States. Specializing as a marketing consultant to lawyers, with a primary focus on content marketing, social media, online video and mobile marketing strategies.
Click Here To Read The Full Article
Navigation 